Vaxxinity News

Vaxxinity | 10-K: Annual report

Mar 27 16:20 ET

Vaxxinity | 8-K: Current report

Mar 14 16:25 ET

Vaxxinity | 8-K: Current report

Feb 15 16:19 ET

Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mei Mei Hu(70.5%)

Feb 12 17:06 ET

Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lou Reese(9.4%)

Feb 12 17:06 ET

Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prime Movers Lab Fund I LP(1.06%),Prime Movers Lab GP I LLC(1.06%), etc.

Feb 7 16:38 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 30 16:08 ET

Vaxxinity | 8-K: Current report

Dec 1, 2023 10:30 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 30, 2023 17:03 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 30, 2023 16:54 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 29, 2023 17:13 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 29, 2023 17:10 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21, 2023 16:21 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21, 2023 16:20 ET

Vaxxinity: Q3 2023 Earnings Report

Nov 8, 2023 07:53 ET

Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Officer Paula Molina Rene

Nov 3, 2023 16:31 ET

Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Director Powchik Peter

Oct 11, 2023 21:42 ET

Vaxxinity | 3: Initial statement of beneficial ownership of securities-Officer Ray Sumita

Oct 11, 2023 21:40 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 4, 2023 16:33 ET

Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 4, 2023 16:24 ET